Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SERPINB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HOPX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H2BL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LHX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMM23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928626 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PTPRM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADH4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORBS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL35A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VIPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on